openPR Logo
Press release

Novel Ocular Drug Delivery Devices Market Business Growth and Opportunities with Valeant Pharmaceuticals, Ocular Therapeutix, Graybug Vision, EyeGate Pharma, Clearside Biomedical, Alimera Sciences, EyeGate Pharma, Envisia Therapeutics, Allergan

09-02-2021 09:07 AM CET | Health & Medicine

Press release from: Report Consultant

Novel Ocular Drug Delivery Devices Market

Novel Ocular Drug Delivery Devices Market

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system.

The three primary methods of delivery of ocular medications to the eye are topical, local ocular (ie, subconjunctival, intravitreal, retrobulbar, intracameral), and systemic. The most appropriate method of administration depends on the area of the eye to be medicated.

Static barriers (different layers of cornea, sclera, and retina including blood aqueous and blood retinal barriers), dynamic barriers (choroidal and conjunctival blood flow, lymphatic clearance, and tear dilution), and efflux pumps in conjunction pose a significant challenge for delivery of a drug alone or in a dosage.

To overcome the ocular drug delivery barriers and improve ocular bioavailability, various conventional and novel drug delivery systems have been developed such as emulsion, ointments, suspensions, aqueous gels, nanomicelles, nanoparticles, liposomes, dendrimers, implants, contact lenses, nanosuspensions, microneedles.

Request a sample copy of report @ https://www.reportconsultant.com/request_sample.php?id=90879

Key Players of Global Novel Ocular Drug Delivery Devices Market:
Valeant Pharmaceuticals International, Inc., Taiwan Liposome Company, Ltd., Ocular Therapeutix, Inc., Graybug Vision Inc., EyeGate Pharma, Clearside Biomedical, Inc., Alimera Sciences, EyeGate Pharma, Envisia Therapeutics, and Allergan, Plc.

The Global Novel Ocular Drug Delivery Devices Market report aims to provide an overview of market with detailed segmentation by organization size, business, industry vertical, and geography. The Global Novel Ocular Drug Delivery Devices Market is expected to witness huge growth during the forecast period. The report provides key statistics on the market status of the leading Novel Ocular Drug Delivery Devices Market players and offers key trends and opportunities in the market.

The report also consists of forecast factors, macroeconomic factors, and a market outlook of the Global Novel Ocular Drug Delivery Devices Market. The study is conducted by applying both top-down and bottom-up approaches and further iterative methods used to validate and size market estimation and trends of the Global Novel Ocular Drug Delivery Devices Market. Additionally to compliment insights EXIM data, consumption, supply and demand Figures, raw price analysis, market revenue and gross margins.

By Type of Drug Delivery Device
• Implants
• Inserts
• Punctal Plugs
By Target Indications
• Glaucoma
• Retinal Vein Occlusion
• Postoperative Ocular Inflammation
• Non-Infectious Uveitis
• Diabetic Macular Edema
• Dry Eye Disease
• Wet Age-related Macular Degeneration
• Retinal Diseases
• Neovascular Age-Related Macular Degeneration
• Other
By Type of Product
• Biodegradable
• Non-biodegradable
By region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle east & Africa

Enquiry Before Buying @ https://www.reportconsultant.com/enquiry_before_buying.php?id=90879

The Global Novel Ocular Drug Delivery Devices Market has been analyzed through industry analysis techniques such as SWOT and Porter's five-technique. The notable feature of this research report is, it offers proper insights into the business by explaining drivers, restraints, and opportunities in front of the business. Industry outlook has been provided by illustrating some significant strategies adopted by them.

Table of Content for Global Novel Ocular Drug Delivery Devices Market:
Chapter 1. Novel Ocular Drug Delivery Devices Market Overview
Chapter 2. Market Competition by Players / Suppliers
Chapter 3. Novel Ocular Drug Delivery Devices Market Sales and Revenue by Regions
Chapter 4. Sales and Revenue by Type
Chapter 5. Novel Ocular Drug Delivery Devices Market Sales and revenue by Application
Chapter 6. Market Players profiles and sales data
Chapter 7. Manufacturing Cost Analysis
Chapter 8. Industrial Chain, Sourcing Strategy and Down Stream Buyers
Chapter 9. Market Strategy Analysis, Distributors/Traders
Chapter 10. Novel Ocular Drug Delivery Devices Market effective factors Analysis
Chapter 11. Market Size and Forecast
Chapter12. Conclusion
Chapter13. Appendix
Continued….

A dedicated chapter on COVID-19 analysis has therefore been included in this multifaceted study to encourage future-ready business discretion aligning with post COVID-19 market environment.

Note- If you have any requirement, let us know and we will customize the report according to your need.

Rebecca Parker
(Report Consultant)
Contact No: +81-368444299
sales@reportconsultant.com
www.reportconsultant.com

About Us:
Report Consultant - A worldwide pacesetter in analytics, research and advisory that can assist you to renovate your business and modify your approach. With us, you will learn to take decisions intrepidly by taking calculative risks leading to lucrative business in the ever-changing market. We make sense of drawbacks, opportunities, circumstances, estimations and information using our experienced skills and verified methodologies.
Our research reports will give you the most realistic and incomparable experience of revolutionary market solutions. We have effectively steered business all over the world through our market research reports with our predictive nature and are exceptionally positioned to lead digital transformations. Thus, we craft greater value for clients by presenting progressive opportunities in the global futuristic market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Novel Ocular Drug Delivery Devices Market Business Growth and Opportunities with Valeant Pharmaceuticals, Ocular Therapeutix, Graybug Vision, EyeGate Pharma, Clearside Biomedical, Alimera Sciences, EyeGate Pharma, Envisia Therapeutics, Allergan here

News-ID: 2378015 • Views: 284

More Releases from Report Consultant

Quantum Cryptography in Banking Market 2021-28 Need of Advancement in Banking wi …
Quantum cryptography is a technology that uses quantum physics to secure the distribution of symmetric encryption keys. According to experts in the field, quantum computers would be able to perform some simulations to forecast future markets, predict the price of options, or assess risk and uncertainty in financial models. IDQ provides QRNGs in various form factors and performances to respond to most use cases encountered in financial applications such as
US Beer Market Shooting Revenue in Upcoming Future| Anheuser-Busch InBev, Molson …
US Beer Market is booming at CAGR +4% by the end of 2028. In 2019-20, Anheuser-Busch InBev was the largest beer company in the world, with sales amounting to approximately 54.6 billion U.S. dollars. Budweiser is an American-style pale lager produced by Anheuser-Busch, has become one of the largest-selling beers in the United States. Bud Light is the most popular beer in the U.S., followed by Coors Light and Miller Lite. Budweiser
Europe LNG Shipping Market Expanding Revenues by 2021-2028| Royal Dutch Shell pl …
Steam turbines are exclusively the primary moving source for LNG ships, even though 2-stroke diesel engines are more efficient. This is because the boil-off gas from LNG needs to be utilized. There are 25 large-scale LNG import terminals in the EU with total regasification capacity of 158.3 mtpa (215.1 bcma),5 enabling LNG to meet approx. 45% of EU gas demand. The world’s largest exporter of liquefied natural gas (LNG) is Qatar,
Behavioural Biometrics Market Exponential Hits $9 Bn by 2021-28 with BioCatch, N …
Behavioural Biometrics Market is projected at USD 9 Billion at a CAGR +20% by the time frame of 2021-28. Behavioral biometrics analyzes a user's digital physical and cognitive behavior and is most commonly used today as a fraud prevention solution. Because each person's interactions with a device are unique, behavioral biometrics can differentiate between the activities of a genuine user and the activities of an imposter. Behavioral biometric verification methods include keystroke

All 5 Releases


More Releases for Ocular

Ocular Hypertension Therapeutics Pipeline Analysis- Clinical Trials, Collaborati …
Ocular hypertension is the increased intraocular pressure in the eyes. If left untreated, the disease can further lead to glaucoma or permanent loss of vision. Clinically, it is estimated that 21 mmHg eye pressure or greater denotes the occurrence of ocular hypertension. The excessive aqueous humour production, inadequate drainage of aqueous humour, eye trauma, and steroidal medications are some of the causes of ocular hypertension. Access Detailed Report Summary at:
Ocular Hypertension - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H2 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor
Ocular Hypertension-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Ocular Hypertension-Pipeline Review H2 2017” this report provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor does not flow through the trabecular meshwork properly, fluid pressure in the eye builds up, causing ocular hypertension. There are no symptoms with ocular hypertension. Risk factors include
Ocular Implants Market Competitive Dynamics & Global Outlook 2024
Global Ocular Implants Market: Overview Ocular implants are used for the medical surgeries that deal with the replacement of the injured eye or to increase the sharpness of the vision. Different types of implants are available in the market which can be used for the treatment of various eye disorders. The implants such as implants for glaucoma surgery, intraocular lenses, corneal implants all these are used to treat the injured or
Ocular Hypertension - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H1 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous
Research Announces: Global Ocular Pain Market
MarketResearchReports.Biz presents this most up-to-date research on "Ocular Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" DelveInsights Report, Ocular Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Ocular Pain Report is to understand the market and pipeline status of the drugs around the